AstraZeneca Pharmaceuticals LP
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 587 Old Baltimore Pike, Newark, Delaware (DE) 19702, United States (USA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 2517100 · DUNS 054743190
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-06-26
- NAIDrug Quality Assurance2023-07-19
- VAIDrug Quality Assurance2017-08-24
- VAIDrug Quality Assurance2014-08-27
- NAIDrug Quality Assurance2011-11-28
- VAIDrug Quality Assurance2011-07-05
- NAIDrug Quality Assurance2009-09-10
Drugs this plant is listed as making
1 distinct drugs across 2 products name this site in their FDA label.
- VandetanibGenzyme Corporation
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.